|
KMID : 1189420230360020001
|
|
Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology
2023 Volume.36 No. 2 p.1 ~ p.9
|
|
|
Analysis of the Active Compounds and Therapeutic Mechanisms of Yijin-tang on Meniere’s Disease Using Network Pharmacology(Ⅱ)
|
|
Jin Sun-Kyung
Nam Hae-Jeong
|
|
|
Abstract
|
|
|
Objectives : This study used a network pharmacology approach to analyze the treatment mechanisms of Yijin-tang on
Meniere’s disease, and comparative analysis the treatment mechanisms of drugs recommended in the Meniere’s disease treatment guidelines.
Methods : We collected information on the recommended drugs from the Meniere’s disease treatment guidelines and their target proteins were screened via the STITCH database. The intersection targets were obtained through Venny 2.1.0. Gene Ontology(GO) analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis were performed using ClueGO.
Results : The 7 proteins(TNF, CASP9, PARP1, CCL2, CFTR, NOS2, NOS1) were associated with both Yijin-tang and Meniere’s disease related genes. The 10 proteins(AQP2, KCNE1, AQP1, AVP, ACE, HRH1, HRH3, NOS1, CA1, CFTR) were associated with both the recommended drugs in the guidelines and Meniere’s disease related genes. The 2 proteins(CFTR, NOS1) were common across all three groups. Further, GO/KEGG pathway analysis of the collected proteins revealed that the common mechanisms of action between Yijin-tang and the recommended drugs in the guidelines were related to pathways involving immune dysfunction and disturbances in lymphatic fluid homeostasis. In addition, the recommended drugs in the guidelines appeared to act through mechanisms that improve blood flow through vasodilation.
Conclusions : Pharmacological network analysis can help to explain the treatment mechanisms of Yijin-tang on Meniere’s disease.
|
|
|
KEYWORD
|
|
|
Yijin-tang, Meniere’s disease, Network pharmacology
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|